Condition: Large B Cell Lymphoma · Sponsor: Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
phase II, response-adaptive, open-label, multicenter study aiming to include 80 patients in 78 months. Patients will receive 3 cycles of epcoritamab monotherapy and, since cycle 4, they can continue with epcoritamab monotherapy until cycle 12 or change to combination therapy (epcoritamab + tafasitamab + lenalidomide) until cycle 15. Patients will be followed up to 5 years.
This description comes directly from the study's public registry record.
Auxi Moreno · +34 683 636 850 · amoreno@geltamo.com
Ana María Méndez · +34 942 203 450 · administracion@geltamo.com
Always discuss trial participation with your own doctor first.
| Hospital Universitario Miguel Servet | Zaragoza, Aragon, Spain | Not Yet Recruiting |
| Hospital Universitario de Burgos | Burgos, Castille and León, Spain | Not Yet Recruiting |
| ICO Badalona | Badalona, Catalonia, Spain | Not Yet Recruiting |
| Hospital Universitari Vall d'Hebrón | Barcelona, Catalonia, Spain | Not Yet Recruiting |
| Hospital San Pedro de Alcántara | Cáceres, Extremadura, Spain | Not Yet Recruiting |
| Hospital General Universitario Gregorio Marañón | Madrid, Madrid, Spain | Recruiting |
| Hospital Universitario Infanta Leonor | Madrid, Madrid, Spain | Not Yet Recruiting |
| Hospital Universitario Fundación Jiménez Díaz | Madrid, Madrid, Spain | Not Yet Recruiting |
| Hospital Virgen de la Arrixaca | El Palmar, Murcia, Spain | Not Yet Recruiting |
| Hospital Universitario Costa del Sol | Marbella, Málaga, Spain | Not Yet Recruiting |
| Hospital Universitario Central de Asturias | Oviedo, Principality of Asturias, Spain | Not Yet Recruiting |
| Hospital Universitario de Canarias | San Cristóbal de La Laguna, Tenerife, Spain | Not Yet Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07126236